Related Experiment Video
Updated: Mar 17, 2026
07:35
Determining Bile Duct Density in the Mouse Liver
Published on: April 30, 2019
7.4K
Molecular diagnostic testing for primary biliary cholangitis
Nikolaos K Gatselis1, George N Dalekos1
1a Department of Medicine and Research Laboratory of Internal Medicine, Medical School , University of Thessaly , Larissa , Greece.
Expert Review of Molecular Diagnostics
|July 28, 2016
Summary
Accurate liver autoimmune serology is crucial for diagnosing primary biliary cholangitis (PBC). Early detection and treatment of PBC can significantly improve patient outcomes and survival rates.
Area of Science:
- Hepatology
- Immunology
- Autoimmune Diseases
Background:
- Primary biliary cholangitis (PBC) diagnosis relies heavily on serology.
- Early recognition and treatment are vital for improving patient outcomes and survival.
- Current diagnostic methods require enhancement for better prognosis.
Purpose of the Study:
- To review current and potential molecular-based diagnostic approaches for PBC.
- To discuss the importance of standardized liver diagnostic serology and clinical governance.
- To explore novel biomarkers for understanding, diagnosing, and managing PBC.
Main Methods:
- Literature search of PubMed and The National Library of Medicine (USA).
- Review and discussion of published data and expert experience.
- Analysis of molecular-based diagnostic strategies and biomarkers.
Main Results:
- Antimitochondrial antibodies are the hallmark of PBC diagnosis.
- PBC-specific antinuclear antibodies aid in diagnosis and prognosis.
- Novel biomarkers including genetic polymorphisms and micro-RNA show promise.
Conclusions:
- Standardization of liver diagnostic serology is essential for PBC diagnosis.
- Emerging biomarkers may enhance the understanding, diagnosis, and management of PBC.
- Prompt diagnosis and treatment initiation can alter PBC progression and improve survival.
